3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Prostatic Neoplasms
4
Endometrial Neoplasms
4
Rectal Neoplasms
3
Colorectal Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Thymoma
2
Obesity, Morbid
2
Neoplasms
2
Kidney Neoplasms
2
Genital Diseases, Female
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Uterine Prolapse
1
Uterine Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Prostatic Diseases
1
Precancerous Conditions
1
Pelvic Organ Prolapse
1
Pancreatic Neuroendocrine Tumors
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Myasthenia Gravis
1
Menstruation Disturbances
1
Mediastinal Neoplasms
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Interventions
Uterine Myomectomy
11
Hysterectomy
3
Vitamin D
2
Vitamin B 6
2
Uterine Artery Embolization
2
Tranexamic Acid
2
Saline Solution
2
Embolization, Therapeutic
2
Bupivacaine
2
Anesthesia, Obstetrical
2
Anesthesia, General
2
gadoterate meglumine
1
epigallocatechin gallate
1
Videotape Recording
1
Vasopressins
1
Vascular Access Devices
1
Tourniquets
1
Thoracic Surgery, Video-Assisted
1
Sodium Chloride
1
Salpingectomy
1
Robotic Surgical Procedures
1
Radiofrequency Ablation
1
Oxytocin
1
Microspheres
1
Leuprolide
1
Hysteroscopy
1
Holistic Health
1
Gonadotropins
1
Gonadotropin-Releasing Hormone
1
Endoscopic Mucosal Resection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Leiomyoma
×
Robotic Surgical Procedures
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled